Evidence map›Paper›PMID 27732336›Full record

Observational studyThe Journal of clinical endocrinology and metabolism2017

Vertebral Volumetric Bone Density and Strength Are Impaired in Women With Low-Weight and Atypical Anorexia Nervosa.

Katherine N Bachmann, Melanie Schorr, Alexander G Bruno, Miriam A Bredella, Elizabeth A Lawson, Corey M Gill, Vibha Singhal, Erinne Meenaghan, Anu V Gerweck, Meghan Slattery and 10 more

Open access · bronzeAbstract readComparative StudyObservational Study
In one paragraph

Observational study in The Journal of clinical endocrinology and metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Trial
  2. QCT-based geometric, densitometric, and biomechanical properties of the aging human thoracolumbar spine.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Anorexia Nervosa and Bone.Current opinion in endocrine and metabolic research · 2018
    Article
  16. Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  17. Review
  18. Eating disorders and bone metabolism in women.Current opinion in pediatrics · 2017
    Review
  19. Defining "significant weight loss" in atypical anorexia nervosa.The International journal of eating disorders · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Katherine N BachmannNeuroendocrine Unit.
Melanie SchorrNeuroendocrine Unit.
Alexander G BrunoHarvard-Massachusetts Institute of Technology Health Sciences and Technology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139.
Miriam A BredellaDepartment of Radiology.
Elizabeth A LawsonNeuroendocrine Unit.
Corey M GillDepartment of Radiology and.
Vibha SinghalNeuroendocrine Unit.
Erinne MeenaghanNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114.
Anu V GerweckNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114.
Meghan SlatteryNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114.
Kamryn T EddyDepartment of Psychiatry, and.
Seda EbrahimiCambridge Eating Disorders Center, Cambridge, Massachusetts, 02138.
Stuart L KomanWalden Behavioral Care, Waltham, Massachusetts, 02453.
James M GreenblattWalden Behavioral Care, Waltham, Massachusetts, 02453.
Robert J KeaneWalden Behavioral Care, Waltham, Massachusetts, 02453.
Thomas WeigelKlarman Center, McLean Hospital, and Harvard Medical School, Belmont, Massachusetts, 02478; and.
Madhusmita MisraNeuroendocrine Unit.
Mary L BouxseinHarvard-Massachusetts Institute of Technology Health Sciences and Technology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139.
Anne KlibanskiNeuroendocrine Unit.
Karen K MillerNeuroendocrine Unit.
Endocrine Society · USMassachusetts General Hospital · USBeth Israel Deaconess Medical Center · USHarvard University · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
ZD6416 Analgesic--Painful Distal Symmetrical PolyneuropaM01RR001066 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI HOGE, ELIZABETH A · 1985 to 2008
$37.4M
Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
IGF-I AND BONE LOSS IN WOMEN WITH ANOREXIA NERVOSAR01DK052625 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KLIBANSKI, ANNE · 1997 to 2015
$6.9M
Biomechanics of Vertebral Fracture: The Framingham QCT StudyR01AR053986 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BOUXSEIN, MARY L · 2007 to 2016
$5.4M
GH, Cardiovascular Risk and Visceral Adiposity in WomenR01HL077674 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, KAREN K · 2007 to 2011
$3.2M
Hormonal Factors in the Treatment of Anorexia NervosaR01MH083657 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI KLIBANSKI, ANNE · 2010 to 2014
$2.1M
Growth Hormone and Cardiovascular DiseaseK24HL092902 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, KAREN K · 2010 to 2019
$1.6M
Bone Metabolism and Body Composition in Young AthletesK24HD071843 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI MISRA, MADHUSMITA · 2013 to 2017
$930k
EFFECTS OF GROWTH HORMONE ON INTRAMYOCELLULAR LIPIDSK23RR023090 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BREDELLA, MIRIAM ANTOINETTE · 2007 to 2011
$813k
NCATS NIH HHS UL1 TR000170NCATS NIH HHS UL1 TR001102NCRR NIH HHS K23 RR023090NCRR NIH HHS M01 RR001066NCRR NIH HHS UL1 RR025758NHLBI NIH HHS K24 HL092902NHLBI NIH HHS R01 HL077674NIAMS NIH HHS R01 AR053986NIA NIH HHS F31 AG041629NICHD NIH HHS K24 HD071843NIDDK NIH HHS R01 DK052625NIDDK NIH HHS T32 DK007028NIMH NIH HHS R01 MH083657
6 · The paper itself

Abstract

Context: Areal bone mineral density (BMD) is lower, particularly at the spine, in low-weight women with anorexia nervosa (AN). However, little is known about vertebral integral volumetric BMD (Int.vBMD) or vertebral strength across the AN weight spectrum, including "atypical" AN [body mass index (BMI) ≥18.5 kg/m2]. Objective: To investigate Int.vBMD and vertebral strength, and their determinants, across the AN weight spectrum. Design: Cross-sectional observational study. Setting: Clinical research center. Participants: 153 women (age 18 to 45): 64 with low-weight AN (BMI <18.5 kg/m2; 58% amenorrheic), 44 with atypical AN (18.5≤BMI<23 kg/m2; 30% amenorrheic), 45 eumenorrheic controls (19.2≤BMI<25 kg/m2). Measures: Int.vBMD and cross-sectional area (CSA) by quantitative computed tomography of L4; estimated vertebral strength (derived from Int.vBMD and CSA). Results: Int.vBMD and estimated vertebral strength were lowest in low-weight AN, intermediate in atypical AN, and highest in controls. CSA did not differ between groups; thus, vertebral strength (calculated using Int.vBMD and CSA) was driven by Int.vBMD. In AN, Int.vBMD and vertebral strength were associated positively with current BMI and nadir lifetime BMI (independent of current BMI). Int.vBMD and vertebral strength were lower in AN with current amenorrhea and longer lifetime amenorrhea duration. Among amenorrheic AN, Int.vBMD and vertebral strength were associated positively with testosterone. Conclusions: Int.vBMD and estimated vertebral strength (driven by Int.vBMD) are impaired across the AN weight spectrum and are associated with low BMI and endocrine dysfunction, both current and previous. Women with atypical AN experience diminished vertebral strength, partially due to prior low-weight and/or amenorrhea. Lack of current low-weight or amenorrhea in atypical AN does not preclude compromise of vertebral strength.

Indexed as

Body WeightAdolescentAdultAmenorrheaAnorexia NervosaBone DensityCase-Control StudiesCross-Sectional StudiesFemaleFollow-Up StudiesHumansMiddle AgedPrognosisSpineThinnessTomography, X-Ray Computed

Identifiers

PMID27732336
PMCPMC5413107
OpenAlexW2530944092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.